• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Antihypertensives in Diabetes Patients with BPs <140 Tied to Higher CV Mortality

MeSci

MeSci

ME/CFS since 1995; activity level 6?
Messages
8,231
Location
Cornwall, UK
From Physician's First Watch:
Antihypertensives in Diabetes Patients with BPs <140 Tied to Higher CV Mortality
By Kelly Young
Edited by
- Susan Sadoughi, MD, and
- Richard Saitz, MD, MPH, FACP, FASAM

Use of antihypertensive treatment is associated with increased cardiovascular mortality in patients with diabetes whose baseline systolic blood pressure is below 140 mm Hg, according to a meta-analysis in The BMJ.

Researchers examined the results of 49 randomized trials of BP-lowering interventions involving 74,000 patients with diabetes, mostly type 2. Patients were followed for roughly 4 years.

Patients with a starting systolic BP above 150 mm Hg saw a 25% reduction in cardiovascular mortality risk with BP-lowering therapy. However, among those with a baseline systolic BP below 140, treatment was associated with a 15% increased CV mortality risk.

The authors speculate that intensive therapy in diabetic patients could affect circulation to end organs and result in ischemia. They note that the recent SPRINT trial, which found a mortality benefit with intensive BP lowering, excluded patients with diabetes.

Link(s):
BMJ article (Free) http://response.jwatch.org/t?ctl=68BB:5FF9B588B7CB016C02435620A62842F2&
Background: NEJM Journal Watch General Medicine coverage of SPRINT study (Free) http://response.jwatch.org/t?ctl=68BC:5FF9B588B7CB016C02435620A62842F2&
Background: NEJM Journal Watch Cardiology coverage of ACCORD study (Free) http://response.jwatch.org/t?ctl=68BD:5FF9B588B7CB016C02435620A62842F2&
Click to expand...
 
*GG*

*GG*

senior member
Messages
6,389
Location
Concord, NH
So CV is CardioVascular, right? Maybe add that to thread title? I clicked on this because I was not sure what CV was, guess I was thinking CMV, CytoMegaloVirus or something?

GG
 
MeSci

MeSci

ME/CFS since 1995; activity level 6?
Messages
8,231
Location
Cornwall, UK
ggingues said:
So CV is CardioVascular, right? Maybe add that to thread title? I clicked on this because I was not sure what CV was, guess I was thinking CMV, CytoMegaloVirus or something?

GG
Click to expand...
It's rather long already. I tried to think of a way to shorten it actually!
 
You must log in or register to reply here.